This second symposium on Gain-of-Function (GOF) research focused on the draft recommendations of the National Science Advisory Board for Biosecurity. The meeting provided a mechanism to engage the ...
BETHESDA, Md., March 05, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next ...
President Trump issued an executive order Monday restricting federal funding for research that involves a controversial field of scientific study known as "gain-of-function" research. The research, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback